<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">AJL</journal-id>
<journal-id journal-id-type="hwp">spajl</journal-id>
<journal-title>American Journal of Lifestyle Medicine</journal-title>
<issn pub-type="ppub">1559-8276</issn>
<issn pub-type="epub">1559-8284</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1559827612462960</article-id>
<article-id pub-id-type="publisher-id">10.1177_1559827612462960</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacy Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Potential Benefits of Cinnamon in Type 2 Diabetes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Howard</surname><given-names>Molly E.</given-names></name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>White</surname><given-names>Nicole D.</given-names></name>
<degrees>PharmD</degrees>
</contrib>
<aff id="aff1-1559827612462960">Creighton University School of Pharmacy and Health Professions, Omaha, Nebraska</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-1559827612462960">Nicole D. White, PharmD, Creighton University School of Pharmacy and Health Professions, 2500 California Plaza, Omaha, NE 68178; e-mail: <email>nicolegillespie@creighton.edu</email>.</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2013</year>
</pub-date>
<volume>7</volume>
<issue>1</issue>
<fpage>23</fpage>
<lpage>26</lpage>
<permissions>
<copyright-statement>© 2013 The Author(s)</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Long known as a spice, cinnamon’s potential efficacy in the treatment of type 2 diabetes has been gaining interest. Evidence from animal models shows efficacy as an insulin mimetic and insulin sensitizing agent, in addition to other potential mechanisms of action. Human clinical data regarding its efficacy have shown inconsistent results but may be related to differentials in baseline glucose control, type of cinnamon used, and duration of study. Overall, a significant number of trials have shown cinnamon to be an effective option for lowering blood sugar in uncontrolled type 2 diabetics. Cinnamon’s reasonable cost, over-the-counter availability, and safety profile make it a relatively low-risk option for this population.</p>
</abstract>
<kwd-group>
<kwd>cinnamon</kwd>
<kwd>diabetes</kwd>
<kwd>HbA1c</kwd>
<kwd>fasting plasma glucose</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>January/February 2013</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>Cinnamon has been used medicinally in traditional Chinese culture for thousands of years.<sup><xref ref-type="bibr" rid="bibr1-1559827612462960">1</xref>,<xref ref-type="bibr" rid="bibr2-1559827612462960">2</xref></sup> In addition to its use as a spice, cinnamon has been used to treat a variety of ailments such as headaches, loss of appetite, dyspepsia, the common cold, inflammation, wounds, nausea, and diarrhea.<sup><xref ref-type="bibr" rid="bibr3-1559827612462960">3</xref><xref ref-type="bibr" rid="bibr4-1559827612462960"/>-<xref ref-type="bibr" rid="bibr5-1559827612462960">5</xref></sup> Cinnamon has also been used to treat the <italic>thirsty disease</italic>, which was the traditional term used for diabetes in China, identifying it by the polydypsia and polyuria that result from excessive hyperglycemia.<sup><xref ref-type="bibr" rid="bibr2-1559827612462960">2</xref></sup></p>
<p>All originating from the bark of trees native to South East Asia from the genus <italic>Cinnamomum</italic>, several species of cinnamon exist, including <italic>Cinnamomum zeylancium</italic> (often referred to as real cinnamon), <italic>Cinnamomum verum</italic> (Ceylon cinnamon), and <italic>Cinnamomum aromaticum</italic> (cassia cinnamon or Chinese cinnamon).<sup><xref ref-type="bibr" rid="bibr3-1559827612462960">3</xref><xref ref-type="bibr" rid="bibr4-1559827612462960"/>-<xref ref-type="bibr" rid="bibr5-1559827612462960">5</xref></sup> Of the species listed, cassia cinnamon has the most favorable data for treating hyperglycemia in type 2 diabetics.<sup><xref ref-type="bibr" rid="bibr1-1559827612462960">1</xref>,<xref ref-type="bibr" rid="bibr5-1559827612462960">5</xref></sup></p>
<p><disp-quote>
<p>In addition to its use as a spice, cinnamon has been used to treat a variety of ailments such as headaches, loss of appetite, dyspepsia, the common cold, inflammation, wounds, nausea, and diarrhea.</p>
</disp-quote></p>
<p>Within the past 10 years, numerous studies have analyzed cassia cinnamon in the treatment of type 2 diabetes. The purpose of this article is to describe cassia cinnamon, summarize the available evidence related to its effect on glycemic control, and discuss its clinical utility including dosage, side effects, precautions, and target treatment populations.</p>
<sec id="section1-1559827612462960">
<title>Potential Mechanisms of Action</title>
<p>Several rodent models and in vitro studies found that cinnamon may have the potential to decrease blood glucose and lipid levels through various mechanisms, some of which mimic the mechanisms of commonly used agents in Western medicine.<sup><xref ref-type="bibr" rid="bibr6-1559827612462960">6</xref><xref ref-type="bibr" rid="bibr7-1559827612462960"/><xref ref-type="bibr" rid="bibr8-1559827612462960"/><xref ref-type="bibr" rid="bibr9-1559827612462960"/><xref ref-type="bibr" rid="bibr10-1559827612462960"/><xref ref-type="bibr" rid="bibr11-1559827612462960"/><xref ref-type="bibr" rid="bibr12-1559827612462960"/><xref ref-type="bibr" rid="bibr13-1559827612462960"/><xref ref-type="bibr" rid="bibr14-1559827612462960"/><xref ref-type="bibr" rid="bibr15-1559827612462960"/>-<xref ref-type="bibr" rid="bibr16-1559827612462960">16</xref></sup></p>
<p>Primarily, cinnamon has been shown to be an insulin mimetic.<sup><xref ref-type="bibr" rid="bibr7-1559827612462960">7</xref><xref ref-type="bibr" rid="bibr8-1559827612462960"/><xref ref-type="bibr" rid="bibr9-1559827612462960"/>-<xref ref-type="bibr" rid="bibr10-1559827612462960">10</xref></sup> In vitro studies show that cinnamon increases cellular glucose uptake and glycogen synthesis in rats with high fructose diets.<sup><xref ref-type="bibr" rid="bibr10-1559827612462960">10</xref>,<xref ref-type="bibr" rid="bibr11-1559827612462960">11</xref></sup> A trial in healthy human subjects found that cinnamon administration reduced postprandial serum insulin and increased glucagon-like peptide 1 (GLP-1) without significantly affecting blood glucose.<sup><xref ref-type="bibr" rid="bibr12-1559827612462960">12</xref></sup> The decrease in serum insulin may indicate a decreased demand for insulin, likely due to enhanced glucose uptake, as discussed previously. The mechanism by which cinnamon increases GLP-1 is unknown, but its effects may be similar to the GLP-1 analogues exenatide and liraglutide, or the dipetidyl-peptidase 4 (DPP4) inhibitors sitagliptin, saxagliptin, and linagliptin.</p>
<p>Cinnamon may also be involved in the activation of peroxisome proliferator–activated receptors (PPAR)-γ and PPAR-α.<sup><xref ref-type="bibr" rid="bibr3-1559827612462960">3</xref>,<xref ref-type="bibr" rid="bibr13-1559827612462960">13</xref>,<xref ref-type="bibr" rid="bibr14-1559827612462960">14</xref></sup> Thiazolidinediones, including pioglitazone and rosiglitazone, target PPAR-γ and promote insulin sensitivity. The fibrate class of anti-hyperlipidemics target PPAR-α, which lowers plasma triglycerides and elevates plasma high-density lipoprotein cholesterol.</p>
<p>Finally, rodent models suggest that cinnamon may inhibit hepatic 3-hydroxy-3-methyl-glutaryl CoA reductase activity.<sup><xref ref-type="bibr" rid="bibr15-1559827612462960">15</xref><xref ref-type="bibr" rid="bibr16-1559827612462960"/>-<xref ref-type="bibr" rid="bibr17-1559827612462960">17</xref></sup> This mechanism parallels that of the popular statin drug class.</p>
</sec>
<sec id="section2-1559827612462960">
<title>Human Clinical Data</title>
<p>Human clinical studies analyzing the glycemic effects of cinnamon have varied results to date, although no large placebo controlled trials currently exist.<sup><xref ref-type="bibr" rid="bibr1-1559827612462960">1</xref>,<xref ref-type="bibr" rid="bibr17-1559827612462960">17</xref><xref ref-type="bibr" rid="bibr18-1559827612462960"/><xref ref-type="bibr" rid="bibr19-1559827612462960"/><xref ref-type="bibr" rid="bibr20-1559827612462960"/><xref ref-type="bibr" rid="bibr21-1559827612462960"/>-<xref ref-type="bibr" rid="bibr22-1559827612462960">22</xref></sup> A study by Lu et al compared 2 strengths of daily cinnamon extract supplementation with placebo.<sup><xref ref-type="bibr" rid="bibr2-1559827612462960">2</xref></sup> The study included 66 Chinese type 2 diabetics treated with gliclazide (a sulfonylurea not marketed in the United States). Lu et al found statistically significant reductions in HbA1c in those receiving 360 mg of cassia cinnamon extract (−0.92%, <italic>P</italic> = .0004) and 120 mg of cassia cinnamon extract (−0.67%, <italic>P</italic> = .003) after 90 days. No significant reductions were seen in the placebo group. Fasting plasma glucose values were also significantly reduced over time in both treatment groups (<italic>P</italic> &lt; .01), whereas triglyceride levels were significantly reduced in the 120-mg group only (<italic>P</italic> &lt; .01).</p>
<p>Another study by Khan et al looked at cinnamon supplementation in 60 type 2 diabetics treated with sulfonylureas.<sup><xref ref-type="bibr" rid="bibr18-1559827612462960">18</xref></sup> The study found statistically significant decreases in mean fasting plasma glucose (FPG; 18% to 29%), triglycerides (23% to 30%), low-density lipoprotein cholesterol (7% to 27%), and total cholesterol (12% to 26%), following supplementation with either 1, 3, or 6 g of cassia cinnamon daily for 40 days. The significant change in FPG over time was similar across the 3 treatment doses while no change was seen in the placebo group.</p>
<p>Crawford conducted a randomized controlled trial simulating “usual care,” in which comorbid conditions, medication changes, and insulin use were allowed in the population.<sup><xref ref-type="bibr" rid="bibr22-1559827612462960">22</xref></sup> It is one of the largest cinnamon trials to date with more than 100 individuals randomized. The study found that supplementation with 1 g of daily cassia cinnamon significantly lowered HbA1c by 0.83% (<italic>P</italic> &lt; .001) from baseline, compared with usual care, which lowered HbA1c by 0.37% (<italic>P</italic> = .16) over 90 days.</p>
<p>In a study of 58 type 2 diabetics, Akilen et al found that patients treated with 2 g of cassia cinnamon daily for 12 weeks showed a statistically significant decrease in mean HbA1c (−0.36%, <italic>P</italic> &lt; .005) as well as systolic (-4 mm Hg, <italic>P</italic> &lt; .001) and diastolic (-4 mm Hg, <italic>P</italic> &lt; .001) blood pressure versus the placebo group.<sup><xref ref-type="bibr" rid="bibr19-1559827612462960">19</xref></sup> The authors noted that HbA1c levels at baseline showed a significant correlation with the degree of decrease in HbA1c at 12 weeks. This finding suggests that those subjects with the highest baseline HbA1c benefit the most from supplementation with cinnamon.</p>
<p>A study by Mang et al found that daily cassia cinnamon extract administration significantly reduced FPG but not HbA1c in 65 type 2 diabetics.<sup><xref ref-type="bibr" rid="bibr17-1559827612462960">17</xref></sup> Fasting plasma glucose was reduced in the treatment group 10.3% versus 3.4% in those receiving placebo (<italic>P</italic> = .046). Similar to the Akilen study, the Mang analysis showed that the degree of glucose lowering was proportional to baseline glucose levels and that subjects with the highest baseline glucose levels saw the greatest reduction.</p>
<p>Interestingly, several of the studies that yielded insignificant effects from cinnamon supplementation looked at patients with lower baseline HbA1c levels. The studies by Lu, Crawford, and Akilen all showed favorable effects of cinnamon in study populations with baseline HbA1c levels &gt;8%. The Khan study showed favorable results, but did not report baseline HbA1c levels. The studies with insignificant results are described below, each with baseline HbA1c levels &lt;8%.</p>
<p>Blevins et al conducted a randomized trial of cinnamon in American type 2 diabetics.<sup><xref ref-type="bibr" rid="bibr20-1559827612462960">20</xref></sup> The study found that taking cassia cinnamon did not yield a significant change in HbA1c after 3 months versus placebo. Baseline HbA1c levels in the Blevins study were relatively low and near HbA1c goal, with means of 7.2 ± 0.3% and 7.1 ± 0.2% in the treatment and control groups, respectively. Vanschoonbeek et al conducted a placebo controlled trial of postmenopausal women, which concluded that cinnamon did not improve whole body insulin sensitivity, oral glucose tolerance, or the blood lipid profile after 30 days.<sup><xref ref-type="bibr" rid="bibr21-1559827612462960">21</xref></sup> Again, the baseline characteristics of the women showed blood glucose levels near goal, with mean HbA1c levels of less than 7.5%. Additionally, 30 days of treatment may not be enough time for changes in HbA1c to be realized. In the Mang study, despite statistically significant decreases in fasting plasma glucose, changes in HbA1c were insignificant. Baseline HbA1c values for participants in the Mang study were below 7%.</p>
</sec>
<sec id="section3-1559827612462960">
<title>Cinnamon Dosing, Side Effects, and Precautions</title>
<p>Between 1 g and 6 g of cassia cinnamon daily for up to 4 months has been studied in the treatment of type 2 diabetes.<sup><xref ref-type="bibr" rid="bibr4-1559827612462960">4</xref>,<xref ref-type="bibr" rid="bibr5-1559827612462960">5</xref></sup> According to the Natural Medicines Comprehensive Database (NMCD), 1 teaspoon of cinnamon spice is equal to 4.75 g.<sup><xref ref-type="bibr" rid="bibr4-1559827612462960">4</xref></sup> Caution must be used when recommending cinnamon purchased as a spice, as this formulation is often a mixture of several species. Only cassia cinnamon has been shown to have a significant effect on glycemic control. Capsules of several strengths of cassia cinnamon are available over the counter. When recommending cinnamon for medicinal benefit, it is likely best for cassia cinnamon capsules to be used.</p>
<p>The side effect profile for cinnamon is relatively mild. The NMCD rates cinnamon as likely safe when used orally within the dosage range suggested (1-6 g daily).<sup><xref ref-type="bibr" rid="bibr4-1559827612462960">4</xref></sup> High-dose, long-term use has been classified as possibly unsafe. There is some concern about ingesting large amounts of cassia cinnamon due to its coumarin content. High daily doses of coumarin (50-700 mg) have been known to cause reversible hepatotoxicity. It is unlikely that such doses would result from cinnamon supplementation; however, caution should be used in those at risk for liver disease.<sup><xref ref-type="bibr" rid="bibr4-1559827612462960">4</xref></sup> Although cases of hypoglycemia have not been documented with cinnamon use, caution should be used when recommending cinnamon to patients already taking insulin or sulfonylureas due to the potential for hypoglycemic effects with these agents.</p>
</sec>
<sec id="section4-1559827612462960">
<title>Discussion</title>
<p>The study of cinnamon supplementation for the treatment of type 2 diabetes has mixed results. There are several hypotheses as to why some studies have produced statistically significant results while others have not. The first is based on the baseline blood glucose levels of those being studied. It is likely that the most significant effect of cinnamon is seen in patients whose baseline blood glucose levels are highest. Second, varied types and extracts of cinnamon have been used, and in a wide range of doses. As only cassia cinnamon has demonstrated clinical efficacy, it is possible that use of other species or combinations of species have contributed to nonsignificant results. Third, studies varied in duration and some may not have had long enough follow-up periods to see significant results.</p>
<p>The use of cinnamon in uncontrolled type 2 diabetic patients has potential for glucose lowering as well as cost savings. The HbA1c reductions seen with cinnamon rival those of commonly prescribed oral antidiabetic agents, whose average A1c lowering range from 0.5% to 1.25%.<sup><xref ref-type="bibr" rid="bibr23-1559827612462960">23</xref></sup> Although some generic oral antidiabetic agents may cost only $12 for a 3-month supply, costs for brand-name DPP-4 inhibitors can exceed $600 for 3 months of treatment.<sup><xref ref-type="bibr" rid="bibr24-1559827612462960">24</xref></sup> In contrast, capsules containing 1 g of cinnamon daily may cost less than $20 for 3 months.<sup><xref ref-type="bibr" rid="bibr25-1559827612462960">25</xref></sup> Because of this, the use of cinnamon in place of or in combination with other antidiabetic agents may result in significantly lower costs to patients.</p>
</sec>
<sec id="section5-1559827612462960">
<title>Conclusion and Clinical Recommendations</title>
<p>Despite the mixed results coming from studies of cinnamon in type 2 diabetic patients, there is promise in its potential effects. Large, randomized, placebo-controlled studies of cinnamon need to be completed in order to fully evaluate its efficacy. However, due to the significant amount of favorable studies in patients with uncontrolled type 2 diabetes, cinnamon is a reasonable treatment option in this population. Cinnamon’s low cost, over-the-counter availability, and safety profile make it a relatively low-risk alternative to traditional glucose-lowering medications. When recommending cinnamon for medicinal benefit, it is likely best for cassia cinnamon capsules to be used rather than use of the spice. Cinnamon spice is generally a mixture of several species of cinnamon, some of which may not be effective at glucose lowering.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="bibr1-1559827612462960">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Davis</surname><given-names>PA</given-names></name>
<name><surname>Yokoyama</surname><given-names>W</given-names></name>
</person-group>. <article-title>Cinnamon intake lowers fasting blood glucose: meta-analysis</article-title>. <source>J Med Food</source>. <year>2011</year>;<volume>14</volume>:<fpage>884</fpage>-<lpage>889</lpage>.</citation>
</ref>
<ref id="bibr2-1559827612462960">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lu</surname><given-names>T</given-names></name>
<name><surname>Sheng</surname><given-names>H</given-names></name>
<name><surname>Wu</surname><given-names>J</given-names></name>
<name><surname>Cheng</surname><given-names>Y</given-names></name>
<name><surname>Zhu</surname><given-names>J</given-names></name>
<name><surname>Chen</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Cinnamon extract improves fasting glycosylated hemoglobin level in Chinese patients with type 2 diabetes</article-title>. <source>Nutr Res</source>. <year>2012</year>;<volume>32</volume>:<fpage>408</fpage>-<lpage>412</lpage>.</citation>
</ref>
<ref id="bibr3-1559827612462960">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rafehi</surname><given-names>H</given-names></name>
<name><surname>Ververis</surname><given-names>K</given-names></name>
<name><surname>Karagiannis</surname><given-names>TC</given-names></name>
</person-group>. <article-title>Controversies surrounding the clinical potential of cinnamon for the management of diabetes</article-title>. <source>Diabetes Obes Metab</source>. <year>2012</year>;<volume>14</volume>:<fpage>493</fpage>-<lpage>499</lpage>.</citation>
</ref>
<ref id="bibr4-1559827612462960">
<label>4.</label>
<citation citation-type="web">Natural Medicine Comprehensive Database. <ext-link ext-link-type="uri" xlink:href="http://www.naturaldatabase.com">http://www.naturaldatabase.com</ext-link>. <access-date>Accessed August 21, 2012</access-date>.</citation>
</ref>
<ref id="bibr5-1559827612462960">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chase</surname><given-names>CK</given-names></name>
<name><surname>McQueen</surname><given-names>CE</given-names></name>
</person-group>. <article-title>Cinnamon in diabetes mellitus</article-title>. <source>Am J Health Syst Pharm</source>. <year>2007</year>;<volume>64</volume>:<fpage>1033</fpage>-<lpage>1035</lpage>.</citation>
</ref>
<ref id="bibr6-1559827612462960">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Preuss</surname><given-names>GH</given-names></name>
<name><surname>Echard</surname><given-names>B</given-names></name>
<name><surname>Polansky</surname><given-names>M</given-names></name>
<name><surname>Anderson</surname><given-names>R</given-names></name>
</person-group>. <article-title>Whole cinnamon and aqueous extracts ameliorate sucrose-induced blood pressure elevations in spontaneously hypertensive rats</article-title>. <source>J Am Coll Nutr</source>. <year>2006</year>;<volume>25</volume>:<fpage>144</fpage>-<lpage>150</lpage>.</citation>
</ref>
<ref id="bibr7-1559827612462960">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jarvill-Taylor</surname><given-names>KJ</given-names></name>
<name><surname>Anderson</surname><given-names>RA</given-names></name>
<name><surname>Graves</surname><given-names>DJ</given-names></name>
</person-group>. <article-title>A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes</article-title>. <source>J Am Coll Nutr</source>. <year>2001</year>;<volume>20</volume>:<fpage>327</fpage>-<lpage>336</lpage>.</citation>
</ref>
<ref id="bibr8-1559827612462960">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Verspohl</surname><given-names>EJ</given-names></name>
<name><surname>Bauer</surname><given-names>K</given-names></name>
<name><surname>Neddermann</surname><given-names>E</given-names></name>
</person-group>. <article-title>Antidiabetic effect of <italic>Cinnamomum cassia</italic> and <italic>Cinnamomum zeylanicum</italic> in vivo and in vitro</article-title>. <source>Phytother Res</source>. <year>2005</year>;<volume>19</volume>:<fpage>203</fpage>-<lpage>206</lpage>.</citation>
</ref>
<ref id="bibr9-1559827612462960">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Anderson</surname><given-names>RA</given-names></name>
<name><surname>Broadhurst</surname><given-names>CL</given-names></name>
<name><surname>Polansky</surname><given-names>MM</given-names></name><etal/>
</person-group>. <article-title>Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity</article-title>. <source>J Agric Food Chem</source>. <year>2004</year>;<volume>52</volume>:<fpage>65</fpage>-<lpage>70</lpage>.</citation>
</ref>
<ref id="bibr10-1559827612462960">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Qin</surname><given-names>B</given-names></name>
<name><surname>Nagasaki</surname><given-names>M</given-names></name>
<name><surname>Ren</surname><given-names>M</given-names></name>
<name><surname>Bajotto</surname><given-names>G</given-names></name>
<name><surname>Oshda</surname><given-names>Y</given-names></name>
<name><surname>Sato</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats</article-title>. <source>Diabetes Res Clin Pract</source>. <year>2003</year>;<volume>62</volume>:<fpage>139</fpage>-<lpage>148</lpage>.</citation>
</ref>
<ref id="bibr11-1559827612462960">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Qin</surname><given-names>B</given-names></name>
<name><surname>Nagasaki</surname><given-names>M</given-names></name>
<name><surname>Ren</surname><given-names>M</given-names></name>
<name><surname>Bajotto</surname><given-names>G</given-names></name>
<name><surname>Oshida</surname><given-names>Y</given-names></name>
<name><surname>Sato</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Cinnamon extract prevents the insulin resistance induced by a high-fructose diet</article-title>. <source>Horm Metab Res</source>. <year>2004</year>;<volume>36</volume>:<fpage>119</fpage>-<lpage>125</lpage>.</citation>
</ref>
<ref id="bibr12-1559827612462960">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hlebowicz</surname><given-names>J</given-names></name>
<name><surname>Darwiche</surname><given-names>G</given-names></name>
<name><surname>Bjorgell</surname><given-names>O</given-names></name>
<name><surname>Almer</surname><given-names>LO</given-names></name>
</person-group>. <article-title>Effect of cinnamon on postprandial blood glucose, gastric emptying, and satiety in healthy subjects</article-title>. <source>Am J Clin Nutr</source>. <year>2007</year>;<volume>85</volume>:<fpage>1552</fpage>-<lpage>1556</lpage>.</citation>
</ref>
<ref id="bibr13-1559827612462960">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sheng</surname><given-names>X</given-names></name>
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<name><surname>Gong</surname><given-names>Z</given-names></name>
<name><surname>Huang</surname><given-names>C</given-names></name>
<name><surname>Zang</surname><given-names>YQ</given-names></name>
</person-group>. <article-title>Improved insulin resistance and lipid metabolism by cinnamon extract through activation of peroxisome proliferator-activated receptors</article-title>. <source>PPAR Res</source>. <year>2008</year>;<volume>2008</volume>:<fpage>581348</fpage>.</citation>
</ref>
<ref id="bibr14-1559827612462960">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>SH</given-names></name>
<name><surname>Choung</surname><given-names>SY</given-names></name>
</person-group>. <article-title>Antihyperglycemic and antihyperlipidemic action of <italic>Cinnamomi cassiae</italic> (cinnamon bark) extract in C57BL/Ks db/db mice</article-title>. <source>Arch Pharm Res</source>. <year>2010</year>;<volume>33</volume>:<fpage>325</fpage>-<lpage>333</lpage>.</citation>
</ref>
<ref id="bibr15-1559827612462960">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>JS</given-names></name>
<name><surname>Jeon</surname><given-names>SM</given-names></name>
<name><surname>Park</surname><given-names>EM</given-names></name><etal/>
</person-group>. <article-title>Cinnamate supplementation enhances hepatic lipid metabolism and antioxidant defense systems in high cholesterol fed rats</article-title>. <source>J Med Food</source>. <year>2003</year>;<volume>6</volume>:<fpage>183</fpage>-<lpage>191</lpage>.</citation>
</ref>
<ref id="bibr16-1559827612462960">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Amin</surname><given-names>KA</given-names></name>
<name><surname>Abd El-Twab</surname><given-names>T</given-names></name>
</person-group>. <article-title>Oxidative markers, nitric oxide, and homocysteine alteration in hypercholesterolimic rats: role of atorvastatine and cinnamon</article-title>. <source>Int J Clin Exp Med</source>. <year>2009</year>;<volume>2</volume>:<fpage>254</fpage>-<lpage>265</lpage>.</citation>
</ref>
<ref id="bibr17-1559827612462960">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mang</surname><given-names>B</given-names></name>
<name><surname>Wolters</surname><given-names>M</given-names></name>
<name><surname>Schmitt</surname><given-names>B</given-names></name><etal/>
</person-group>. <article-title>Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2</article-title>. <source>Eur J Clin Invest</source>. <year>2006</year>;<volume>36</volume>:<fpage>340</fpage>-<lpage>344</lpage>.</citation>
</ref>
<ref id="bibr18-1559827612462960">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Khan</surname><given-names>A</given-names></name>
<name><surname>Safdar</surname><given-names>M</given-names></name>
<name><surname>Ali Khan</surname><given-names>MM</given-names></name>
<name><surname>Khattak</surname><given-names>KN</given-names></name>
<name><surname>Anderson</surname><given-names>RA</given-names></name>
</person-group>. <article-title>Cinnamon improves glucose and lipids of people with type 2 diabetes</article-title>. <source>Diabetes Care</source>. <year>2003</year>;<volume>26</volume>: <fpage>3215</fpage>-<lpage>3218</lpage>.</citation>
</ref>
<ref id="bibr19-1559827612462960">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Akilen</surname><given-names>R</given-names></name>
<name><surname>Tsiami</surname><given-names>A</given-names></name>
<name><surname>Devendra</surname><given-names>D</given-names></name>
<name><surname>Robinson</surname><given-names>N</given-names></name>
</person-group>. <article-title>Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial</article-title>. <source>Diabet Med</source>. <year>2010</year>;<volume>27</volume>:<fpage>1159</fpage>-<lpage>1167</lpage>.</citation>
</ref>
<ref id="bibr20-1559827612462960">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blevins</surname><given-names>SM</given-names></name>
<name><surname>Leyva</surname><given-names>MJ</given-names></name>
<name><surname>Brown</surname><given-names>J</given-names></name>
<name><surname>Wright</surname><given-names>J</given-names></name>
<name><surname>Scofield</surname><given-names>RH</given-names></name>
<name><surname>Aston</surname><given-names>CE</given-names></name>
</person-group>. <article-title>Effect of cinnamon on glucose and lipid levels in non insulin-dependent type 2 diabetes</article-title>. <source>Diabetes Care</source>. <year>2007</year>;<volume>30</volume>:<fpage>2236</fpage>-<lpage>2237</lpage>.</citation>
</ref>
<ref id="bibr21-1559827612462960">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vanschoonbeek</surname><given-names>K</given-names></name>
<name><surname>Thomassen</surname><given-names>BJ</given-names></name>
<name><surname>Senden</surname><given-names>JM</given-names></name>
<name><surname>Wodzig</surname><given-names>WK</given-names></name>
<name><surname>van Loon</surname><given-names>LJ</given-names></name>
</person-group>. <article-title>Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients</article-title>. <source>J Nutr</source>. <year>2006</year>;<volume>136</volume>:<fpage>977</fpage>-<lpage>980</lpage>.</citation>
</ref>
<ref id="bibr22-1559827612462960">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Crawford</surname><given-names>P</given-names></name>
</person-group>. <article-title>Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial</article-title>. <source>J Am Board Fam Med</source>. <year>2009</year>;<volume>22</volume>:<fpage>507</fpage>-<lpage>512</lpage>.</citation>
</ref>
<ref id="bibr23-1559827612462960">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sherifall</surname><given-names>D</given-names></name>
<name><surname>Cheng</surname><given-names>JE</given-names></name>
<name><surname>Nerenberg</surname><given-names>K</given-names></name>
<name><surname>Gerstein</surname><given-names>HC</given-names></name>
<name><surname>Pullenayegum</surname><given-names>E</given-names></name>
</person-group>. <article-title>The effect of oral antidiabetic agents on A1c levels: a systematic review and meta-analysis</article-title>. <source>Diabetes Care</source>. <year>2010</year>;<volume>33</volume>:<fpage>1859</fpage>-<lpage>1864</lpage>.</citation>
</ref>
<ref id="bibr24-1559827612462960">
<label>24.</label>
<citation citation-type="web">
<collab>Red Book Online Web site</collab>. <ext-link ext-link-type="uri" xlink:href="http://www-thomsonhc-com.cuhsl.creighton.edu/micromedex2/librarian/ND_T/evidencexpert/ND_PR/evidencexpert/CS/501DCC/ND_AppProduct/evidencexpert/DUPLICATIONSHIELDSYNC/7BDC11/ND_PG/evidencexpert/ND_B/evidencexpert/ND_P/evidencexpert/PFActionId/redbook.FindRedBook">http://www-thomsonhc-com.cuhsl.creighton.edu/micromedex2/librarian/ND_T/evidencexpert/ND_PR/evidencexpert/CS/501DCC/ND_AppProduct/evidencexpert/DUPLICATIONSHIELDSYNC/7BDC11/ND_PG/evidencexpert/ND_B/evidencexpert/ND_P/evidencexpert/PFActionId/redbook.FindRedBook</ext-link>. <access-date>Accessed August 30, 2012</access-date>.</citation>
</ref>
<ref id="bibr25-1559827612462960">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fairman</surname><given-names>KA</given-names></name>
<name><surname>Curtiss</surname><given-names>FR</given-names></name>
</person-group>. <article-title>Call for comparative effectiveness research: lowering A1c with sitagliptin, saxagliptin, or cinnamon</article-title>. <source>J Manag Care Pharm</source>. <year>2009</year>;<volume>15</volume>:<fpage>696</fpage>-<lpage>700</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>